Sri Kosaraju

Sri Kosaraju serves as a Board Member at Manus since April 2025, contributing to the acceleration of biologically produced alternatives. Kosaraju has been involved with 10x Genomics as Audit Chair and Board Member since April 2019, supporting advancements in life science technology. Prior experience includes serving as a Board Member at Nevro from August 2021 until its acquisition by Globus in April 2025, and as Chief Executive Officer at Inscripta, Inc. from October 2020 to April 2025, prior to its merger with Manus Bio. Additional roles include President and Chief Financial Officer at Penumbra, Inc. from May 2015 to May 2020, and Managing Director at J.P. Morgan from 1999 to 2015, leading the Healthcare and TMT Equity Capital Markets divisions. Sri Kosaraju holds a Bachelor of Science degree in Mechanical Engineering from the Massachusetts Institute of Technology, graduating in 1999.